{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:22:38Z","timestamp":1780546958126,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The risk of vessel-oriented cardiac adverse events (VOCE) in patients with diabetes mellitus (DM) undergoing intracoronary physiology-guided coronary revascularization is poorly defined. The purpose of this work is to evaluate the risk of VOCE in patients with and without DM in whom percutaneous coronary intervention (PCI) was performed or deferred based on pressure-wire functional assessment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a retrospective analysis of a multicenter registry of patients evaluated with fractional flow reserve (FFR) and\/or non-hyperaemic pressure ratio (NHPR). Primary endpoint was a composite of VOCE including cardiac death, vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (TVR).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A large cohort of 2828 patients with 3353 coronary lesions was analysed to assess the risk of VOCE at long-term follow-up (23 [14\u201336] months). Non-insulin-dependent-DM (NIDDM) was not associated with the primary endpoint in the overall cohort (adjusted Hazard Ratio [aHR] 1.18, 95% CI 0.87\u20131.59, <jats:italic>P<\/jats:italic>\u2009=\u20090.276) or in patients with coronary lesions treated with PCI (aHR\u2009=\u20091.30, 95% CI 0.78\u20132.16, <jats:italic>P<\/jats:italic>\u2009=\u20090.314). Conversely, insulin-dependent diabetes mellitus (IDDM) demonstrated an increased risk of VOCE in the overall cohort (aHR 1.76, 95% CI 1.07\u20132.91, <jats:italic>P<\/jats:italic>\u2009=\u20090.027), but not in coronary lesions undergoing PCI (aHR 1.26, 95% CI 0.50\u20133.16, <jats:italic>P<\/jats:italic>\u2009=\u20090.621). Importantly, in coronary lesions deferred after functional assessment IDDM (aHR 2.77, 95% CI 1.11\u20136.93, <jats:italic>P<\/jats:italic>\u2009=\u20090.029) but not NIDDM (aHR\u2009=\u20090.94, 95% CI 0.61\u20131.44, <jats:italic>P<\/jats:italic>\u2009=\u20090.776) was significantly associated with the risk of VOCE. IDDM caused a significant effect modification of FFR-based risk stratification (<jats:italic>P<\/jats:italic> for interaction\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Overall, DM was not associated with an increased risk of VOCE in patients undergoing physiology-guided coronary revascularization. However, IDDM represents a phenotype at high risk of VOCE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00392-023-02243-y","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T09:02:20Z","timestamp":1687251740000},"page":"1331-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-8882","authenticated-orcid":false,"given":"Roberto","family":"Scarsini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Tebaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sgreva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vescovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Barbierato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Vicer\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Galante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Mammone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Tavella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Pesarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Maria","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio Luciano","family":"Ribichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"issue":"14","key":"2243_CR1","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.4244\/EIJY19M01_01","volume":"14","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. EuroIntervention 14(14):1435\u20131534","journal-title":"EuroIntervention"},{"issue":"2","key":"2243_CR2","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jacc.2021.09.006","volume":"79","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM et al (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint\u00a0Committee\u00a0on\u00a0Clinical Practice Guidelines. J Am Coll Cardiol 79(2):e21\u2013e129","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2243_CR3","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.4244\/EIJY15M03_09","volume":"11","author":"M Leung","year":"2016","unstructured":"Leung M, Leung DY (2016) Coronary microvascular function in patients with type 2 diabetes mellitus. EuroIntervention 11(10):1111\u20131117","journal-title":"EuroIntervention"},{"issue":"24","key":"2243_CR4","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jcin.2018.09.033","volume":"11","author":"M Konigstein","year":"2018","unstructured":"Konigstein M, Ben-Yehuda O, Smits PC, Love MP, Banai S, Perlman GY et al (2018) Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: analysis from the BIONICS randomized trial. JACC Cardiovasc Interv 11(24):2467\u20132476","journal-title":"JACC Cardiovasc Interv"},{"issue":"25","key":"2243_CR5","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","volume":"120","author":"BR Chaitman","year":"2009","unstructured":"Chaitman BR, Hardison RM, Adler D, Gebhart S, Grogan M, Ocampo S et al (2009) The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction. Circulation 120(25):2529\u20132540","journal-title":"Circulation"},{"issue":"17","key":"2243_CR6","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.121.054439","volume":"144","author":"JD Newman","year":"2021","unstructured":"Newman JD, Anthopolos R, Mancini GBJ, Bangalore S, Reynolds HR, Kunichoff DF et al (2021) Outcomes of participants with diabetes in the ISCHEMIA trials. Circulation 144(17):1380\u20131395","journal-title":"Circulation"},{"issue":"2","key":"2243_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"F Cosentino","year":"2020","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V et al (2020) 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 41(2):255\u2013323","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"2243_CR8","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"AD Association","year":"2021","unstructured":"Association AD (2021) 2. Classification and diagnosis of diabetes. Diabetes Care 44(Suppl 1):S15\u2013S33","journal-title":"Diabetes Care"},{"issue":"3","key":"2243_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","volume":"40","author":"K Thygesen","year":"2019","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA et al (2019) Fourth universal definition of myocardial infarction (2018). Eur Heart J 40(3):237\u2013269","journal-title":"Eur Heart J"},{"issue":"5","key":"2243_CR10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jcin.2013.12.201","volume":"7","author":"KW Park","year":"2014","unstructured":"Park KW, Lee JM, Kang SH, Ahn HS, Kang HJ, Koo BK et al (2014) Everolimus-eluting Xience v\/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus. JACC Cardiovasc Interv 7(5):471\u2013481","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"2243_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.114.002328","volume":"8","author":"V Ritsinger","year":"2015","unstructured":"Ritsinger V, Saleh N, Lagerqvist B, Norhammar A (2015) High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus: results from the Swedish coronary angiography and angioplasty registry. Circ Cardiovasc Interv 8(6):e002328","journal-title":"Circ Cardiovasc Interv"},{"issue":"9","key":"2243_CR12","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/jamacardio.2019.2298","volume":"4","author":"JM Lee","year":"2019","unstructured":"Lee JM, Choi KH, Koo BK, Dehbi HM, Doh JH, Nam CW et al (2019) Comparison of major adverse cardiac events between instantaneous wave-free ratio and fractional flow reserve-guided strategy in patients with or without type 2 diabetes: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 4(9):857\u2013864","journal-title":"JAMA Cardiol."},{"issue":"8","key":"2243_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/eurheartj\/ehu412","volume":"36","author":"JP Depta","year":"2015","unstructured":"Depta JP, Patel JS, Novak E, Gage BF, Masrani SK, Raymer D et al (2015) Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment. Eur Heart J 36(8):509\u2013515","journal-title":"Eur Heart J"},{"issue":"14","key":"2243_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12933-015-0300-6","volume":"07","author":"PK Bundhun","year":"2015","unstructured":"Bundhun PK, Li N, Chen MH (2015) Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis. Cardiovasc Diabetol 07(14):135","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2243_CR15","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.amjcard.2018.02.034","volume":"121","author":"SH Pi","year":"2018","unstructured":"Pi SH, Rhee TM, Lee JM, Hwang D, Park J, Park TK et al (2018) Outcomes in patients with diabetes mellitus according to insulin treatment after percutaneous coronary intervention in the second-generation drug-eluting stent era. Am J Cardiol 121(12):1505\u20131511","journal-title":"Am J Cardiol"},{"issue":"7","key":"2243_CR16","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1002\/ccd.27002","volume":"90","author":"MW Kennedy","year":"2017","unstructured":"Kennedy MW, Fabris E, Hermanides RS, Kaplan E, Borren N, Berta B et al (2017) Factors associated with deferred lesion failure following fractional flow reserve assessment in patients with diabetes mellitus. Catheter Cardiovasc Interv 90(7):1077\u20131083","journal-title":"Catheter Cardiovasc Interv"},{"issue":"21","key":"2243_CR17","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.jacc.2016.08.055","volume":"68","author":"E Barbato","year":"2016","unstructured":"Barbato E, Toth GG, Johnson NP, Pijls NH, Fearon WF, Tonino PA et al (2016) Prospective natural history study of\u00a0coronary atherosclerosis using fractional flow reserve. J Am Coll Cardiol 68(21):2247\u20132255","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2243_CR18","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jacc.2014.06.1182","volume":"64","author":"GD Dangas","year":"2014","unstructured":"Dangas GD, Farkouh ME, Sleeper LA, Yang M, Schoos MM, Macaya C et al (2014) Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. J Am Coll Cardiol 64(12):1189\u20131197","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2243_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2337\/diabetes.52.7.1851","volume":"52","author":"R Barazzoni","year":"2003","unstructured":"Barazzoni R, Kiwanuka E, Zanetti M, Cristini M, Vettore M, Tessari P (2003) Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes. Diabetes 52(7):1851\u20131856","journal-title":"Diabetes"},{"issue":"1","key":"2243_CR20","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jdiacomp.2012.08.008","volume":"27","author":"MY Wang","year":"2013","unstructured":"Wang MY, Yu X, Lee Y, McCorkle SK, Clark GO, Strowig S et al (2013) Iatrogenic hyperinsulinemia in type 1 diabetes: its effect on atherogenic risk markers. J Diabetes Complic 27(1):70\u201374","journal-title":"J Diabetes Complic"},{"issue":"6","key":"2243_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jcin.2014.11.025","volume":"8","author":"M Kuroda","year":"2015","unstructured":"Kuroda M, Shinke T, Sakaguchi K, Otake H, Takaya T, Hirota Y et al (2015) Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study. JACC Cardiovasc Interv 8(6):800\u2013811","journal-title":"JACC Cardiovasc Interv"},{"issue":"45","key":"2243_CR22","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1093\/eurheartj\/ehab433","volume":"42","author":"E Kedhi","year":"2021","unstructured":"Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AJJ et al (2021) Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial. Eur Heart J 42(45):4671\u20134679","journal-title":"Eur Heart J"},{"issue":"3","key":"2243_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1001\/jamacardio.2019.5097","volume":"5","author":"E Van Belle","year":"2020","unstructured":"Van Belle E, Cosenza A, Baptista SB, Vincent F, Henderson J, Santos L et al (2020) Usefulness of routine fractional flow reserve for clinical management of coronary artery disease in patients with diabetes. JAMA Cardiol. 5(3):272\u2013281","journal-title":"JAMA Cardiol."},{"issue":"6","key":"2243_CR24","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/S0735-1097(97)00327-6","volume":"30","author":"I Yokoyama","year":"1997","unstructured":"Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y et al (1997) Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 30(6):1472\u20131477","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2243_CR25","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0735-1097(03)00166-9","volume":"41","author":"MF Di Carli","year":"2003","unstructured":"Di Carli MF, Janisse J, Grunberger G, Ager J (2003) Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41(8):1387\u20131393","journal-title":"J Am Coll Cardiol"},{"issue":"245","key":"2243_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ijcard.2017.07.099","volume":"15","author":"JM Lee","year":"2017","unstructured":"Lee JM, Shin ES, Nam CW, Doh JH, Hwang D, Park J et al (2017) Discrepancy between fractional flow reserve and instantaneous wave-free ratio: clinical and angiographic characteristics. Int J Cardiol 15(245):63\u201368","journal-title":"Int J Cardiol"},{"issue":"3","key":"2243_CR27","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1002\/ccd.30007","volume":"99","author":"R Scarsini","year":"2022","unstructured":"Scarsini R, Fezzi S, Pesarini G, Del Sole PA, Venturi G, Mammone C et al (2022) Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy. Catheter Cardiovasc Interv 99(3):736\u2013745","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"2243_CR28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jcmg.2015.12.023","volume":"10","author":"E Kedhi","year":"2017","unstructured":"Kedhi E, Kennedy MW, Maehara A, Lansky AJ, McAndrew TC, Marso SP et al (2017) Impact of TCFA on unanticipated ischemic events in medically treated diabetes mellitus: insights from the PROSPECT Study. JACC Cardiovasc Imaging 10(4):451\u2013458","journal-title":"JACC Cardiovasc Imaging"},{"issue":"14","key":"2243_CR29","doi-asserted-by":"publisher","first-page":"e009245","DOI":"10.1161\/JAHA.118.009245","volume":"7","author":"T Sugiyama","year":"2018","unstructured":"Sugiyama T, Yamamoto E, Bryniarski K, Xing L, Fracassi F, Lee H et al (2018) Coronary plaque characteristics in patients with diabetes mellitus who presented with acute coronary syndromes. J Am Heart Assoc 7(14):e009245","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"2243_CR30","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.121.011728","volume":"15","author":"E Fabris","year":"2022","unstructured":"Fabris E, Berta B, Roleder T, Hermanides RS, IJsselmuiden AJJ, Kauer F et al (2022) Thin-cap fibroatheroma rather than any lipid plaques increases the risk of cardiovascular events in diabetic patients: insights from the COMBINE OCT-FFR Trial. Circ Cardiovasc Interv 15(5):e011728","journal-title":"Circ Cardiovasc Interv"},{"issue":"16","key":"2243_CR31","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012741","volume":"8","author":"A Wester","year":"2019","unstructured":"Wester A, Attar R, Mohammad MA, Andell P, Hofmann R, Jensen J et al (2019) Impact of baseline anemia in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a prespecified analysis from the VALIDATE-SWEDEHEART Trial. J Am Heart Assoc 8(16):e012741","journal-title":"J Am Heart Assoc"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02243-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02243-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02243-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T14:13:20Z","timestamp":1692886400000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02243-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2243"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02243-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"R.S. reports research grants from Abbott Vascular and Medis and received speaking honoraria from Abbott. M.T. reports speaking honoraria from Abbott. G.C. reports research grant from Abbott. A.M.L. is a consultant for Abbott Vascular and received speaking honoraria from Medtronic, Abiomed and Bracco\/Acist Imaging. The other authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}